1 Min Read
Aug 10 (Reuters) - Knight Therapeutics Inc
* Knight reports second quarter 2017 results
* Qtrly shr $0.003
* All figures in C$ Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.